WallStreetZenWallStreetZen

NYSE: CRL
Charles River Laboratories International Inc Stock Ownership - Who owns Charles River Laboratories International?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Charles River Laboratories International Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Abraham CeesayDirector2025-06-02946$135.04
$127.75kBuy
Steven BargDirector2025-06-02481$135.04
$64.95kBuy
Steven BargDirector2025-06-02946$135.04
$127.75kBuy
Paul W. GravesDirector2025-06-02946$135.04
$127.75kBuy
Mark J. EnyedyDirector2025-06-02946$135.04
$127.75kBuy
Michael Gunnar KnellCSVPChief Accounting Officer2025-06-01225$135.63
$30.52kSell
Michael Gunnar KnellCSVPChief Accounting Officer2025-05-3148$135.63
$6.51kSell
Victoria L. CreamerEVP Chief People Officer2025-05-31120$135.63
$16.28kSell
Joseph W. LaplumeEVP Corp Strategy Develop2025-05-31155$135.63
$21.02kSell
Shannon M. ParisottoCEVP Disc Safety Assessment2025-05-31105$135.63
$14.24kSell

1 of 7

CRL insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CRL insiders and whales buy or sell their stock.

CRL Shareholders

What type of owners hold Charles River Laboratories International Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Vanguard Group Inc12.43%6,105,478$915.88MInstitution
Wellington Management Group LLP8.72%4,285,012$642.79MInstitution
Blackrock Inc7.47%3,670,825$550.66MInstitution
Ubs Group Ag4.87%2,391,785$358.79MInstitution
Kayne Anderson Rudnick Investment Management LLC3.97%1,950,273$292.56MInstitution
State Street Corp3.87%1,902,625$285.41MInstitution
Allspring Global Investments Holdings LLC3.61%1,774,605$266.21MInstitution
Geode Capital Management LLC2.57%1,263,665$189.56MInstitution
Impactive Capital LP2.47%1,211,538$181.74MInstitution
Invesco Ltd2.26%1,108,358$166.26MInstitution

1 of 3

CRL vs Diagnostic & Research Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CRL96.73%3.27%Net BuyingNet Buying
GH65.37%34.63%Net SellingNet Selling
MEDP27.73%72.27%Net BuyingNet Buying
EXAS96.68%3.32%Net SellingNet Selling
QGEN73.65%0.00%
View Top Diagnostic & Research Stocks

Charles River Laboratories International Stock Ownership FAQ

Who owns Charles River Laboratories International?

Charles River Laboratories International (NYSE: CRL) is owned by 107.82% institutional shareholders, 3.64% Charles River Laboratories International insiders, and 0.00% retail investors. Vanguard Group Inc is the largest individual Charles River Laboratories International shareholder, owning 6.11M shares representing 12.43% of the company. Vanguard Group Inc's Charles River Laboratories International shares are currently valued at $926.38M.

If you're new to stock investing, here's how to buy Charles River Laboratories International stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.